PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Metabolic & Glycemic Control/Fructosamine
Metabolic & Glycemic ControlIntermediate Glycemic Monitoring (2-3 Weeks)

Serum Fructosamine (Fructosamine)

Serum fructosamine measures total glycated serum proteins (predominantly albumin), reflecting mean circulating glucose concentrations over the preceding 2 to 3 weeks.

Standard Range200 - 285 μmol/L
Optimal Longevity200 - 240 μmol/L
Measurement Unitμmol/L
Organ SystemIntermediate Glycemic Monitoring (2-3 Weeks)
Routine Panels:Specialty Glycemic PanelShort-Term Glycation Index

Standard vs. Optimal Reference Rangesμmol/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: μmol/L
μmol/L
Presets:
140 μmol/LOptimal Zone Target385 μmol/L
Optimal Longevity Zone(220 μmol/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

200 - 285 μmol/L

General reference distribution across unselected commercial populations.

Optimal Longevity Target

200 - 240 μmol/L

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Glucose ketoamines form when glucose condenses non-enzymatically with protein amino groups. Because albumin turnover occurs every 14-21 days, fructosamine captures glycemic shifts far earlier than HbA1c.

Differential Diagnosis

Elevated Levels (Fructosamine High)

  • •Short-term glycemic decompensation
  • •Rapid diabetic progression

Low Levels (Fructosamine Low)

  • •Hypoalbuminemia / Nephrotic syndrome (requires albumin correction)
  • •Severe hyperthyroidism

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
The physiological homeostasis of Serum Fructosamine (Fructosamine) is governed by pancreatic islet beta-cell secretion, hepatic gluconeogenesis, skeletal muscle GLUT4 glucose transporter translocation, and peripheral insulin sensitivity. Cellular signal transduction occurs via the insulin receptor tyrosine kinase (IRTK), triggering phosphorylation of IRS-1 and IRS-2, which activates the phosphatidylinositol 3-kinase (PI3K)-Akt cascade and downregulates FOXO1 transcription factors. Impaired signaling causes systemic hyperinsulinemia, attenuated mitochondrial beta-oxidation, and accelerated hepatic de novo lipogenesis (DNL).
Longevity Risk Architecture & Epidemiology
Essential for assessing glycemic response to dietary and lifestyle interventions without waiting 3 months for erythrocyte turnover.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Strict 10 to 12 hour overnight water-only fasting is mandatory for baseline metabolic quantification. Acute psychological stress, acute infectious illness, and sleep deprivation (<6 hours) transiently elevate cortisol and catecholamines, falsely elevating glycemic markers. For glucose and insulin testing, draw blood into sodium fluoride/potassium oxalate tubes or separate serum promptly within 30 minutes to prevent ongoing in vitro red blood cell glycolysis.

Reflexive Testing Protocol:

  • Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and HOMA-Beta calculations
  • Continuous Glucose Monitoring (CGM) 14-day wear to evaluate glycemic variability and postprandial excursions
  • Fasting C-Peptide and high-sensitivity Troponin/hs-CRP to differentiate insulin resistance from beta-cell exhaustion
  • Oral Glucose Tolerance Test (OGTT) with simultaneous 0, 30, 60, and 120-minute insulin assays
  • Abdominal ultrasound or FibroScan to evaluate hepatic steatosis and non-alcoholic fatty liver disease (MASLD)
Clinical Citations & Primary Literature (1)
  • [1]Fructosamine and Glycated Albumin for Risk Stratification in Diabetes - Lancet Diabetes & Endocrinology (2021). PMID: 33711289
Common Panels:Specialty Glycemic PanelShort-Term Glycation Index
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Fructosamine (Fructosamine) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Metabolic & Glycemic Control Biomarkers

Hemoglobin A1c
HbA1c · 4.8% - 5.2%
Fasting Blood Glucose
FBG · 75 - 85 mg/dL
Serum Albumin
Albumin · 4.5 - 5.0 g/dL
PreviousC-Peptide (Connecting Peptide) (C-Peptide)Metabolic & Glycemic ControlNextSerum Leptin (Leptin)Metabolic & Glycemic Control